T1 Protein 615 621 tumour
T2 Intervention 420 426 plasma
T3 Condition 746 751 EphA2
T4 Condition 893 898 EphA2
T5 Biomarker 458 477 antibody-conjugated
T6 Condition 793 798 EphA2
T7 Organism 849 870 pancreatitis patients
T8 Biomarker 527 549 EV-specific antibodies
T9 Condition 793 843 EphA2-EVs distinguishes pancreatic cancer patients
T10 Protein 375 393 tumour-derived EVs
T11 Protein 936 942 tumour
T12 Protein 375 381 tumour
